Literature DB >> 7584117

Gene delivery into the central nervous system by nasal instillation in rats.

R Draghia1, C Caillaud, R Manicom, A Pavirani, A Kahn, L Poenaru.   

Abstract

Replication-deficient adenoviruses have been used successfully to transfer foreign DNA into postmitotic cells. This article demonstrates that it is possible to transfer the Escherichia coli lacZ gene in vivo into the central nervous system structures of rats after nasal instillation of replication-defective adenoviral vector AdRSV beta gal. Mitral cells from the olfactory bulb, neurons from the anterior olfactory nucleus, locus coeruleus and area postrema expressed beta-galactosidase for at least 12 days. No cytopathic effect was observed in the CNS structures studied at the viral titer used (1-3 x 10(9) plaque-forming units (p.f.u.)). This method could be useful for the gene therapy of diseases affecting different CNS structures.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7584117

Source DB:  PubMed          Journal:  Gene Ther        ISSN: 0969-7128            Impact factor:   5.250


  11 in total

Review 1.  Progress on adenovirus-vectored universal influenza vaccines.

Authors:  Kui Xiang; Guan Ying; Zhou Yan; Yan Shanshan; Zhang Lei; Li Hongjun; Sun Maosheng
Journal:  Hum Vaccin Immunother       Date:  2015       Impact factor: 3.452

2.  Localization of CART-positive neurons in the amygdaloid body and the relationship between their immunoreactivity and the sex steroid level.

Authors:  A V Akhmadeev
Journal:  Neurosci Behav Physiol       Date:  2010-03-26

3.  Demonstration of Direct Nose-to-Brain Transport of Unbound HIV-1 Replication Inhibitor DB213 Via Intranasal Administration by Pharmacokinetic Modeling.

Authors:  Qianwen Wang; Yufeng Zhang; Chun-Ho Wong; H Y Edwin Chan; Zhong Zuo
Journal:  AAPS J       Date:  2017-12-27       Impact factor: 4.009

Review 4.  Emerging Insights for Translational Pharmacokinetic and Pharmacokinetic-Pharmacodynamic Studies: Towards Prediction of Nose-to-Brain Transport in Humans.

Authors:  Mitchel J R Ruigrok; Elizabeth C M de Lange
Journal:  AAPS J       Date:  2015-02-19       Impact factor: 4.009

5.  Filamentous phage as vector-mediated antibody delivery to the brain.

Authors:  Dan Frenkel; Beka Solomon
Journal:  Proc Natl Acad Sci U S A       Date:  2002-04-16       Impact factor: 11.205

6.  Nanotechnology for CNS delivery of bio-therapeutic agents.

Authors:  Lipa Shah; Sunita Yadav; Mansoor Amiji
Journal:  Drug Deliv Transl Res       Date:  2013-08-01       Impact factor: 4.617

Review 7.  Strategies for intranasal delivery of therapeutics for the prevention and treatment of neuroAIDS.

Authors:  Leah R Hanson; William H Frey
Journal:  J Neuroimmune Pharmacol       Date:  2006-09-15       Impact factor: 4.147

Review 8.  Drug delivery systems for the treatment of ischemic stroke.

Authors:  Taiyoun Rhim; Dong Yun Lee; Minhyung Lee
Journal:  Pharm Res       Date:  2013-01-10       Impact factor: 4.200

Review 9.  Advances and future challenges in recombinant adenoviral vectored H5N1 influenza vaccines.

Authors:  Jianfeng Zhang
Journal:  Viruses       Date:  2012-11-01       Impact factor: 5.048

Review 10.  Intranasal delivery bypasses the blood-brain barrier to target therapeutic agents to the central nervous system and treat neurodegenerative disease.

Authors:  Leah R Hanson; William H Frey
Journal:  BMC Neurosci       Date:  2008-12-10       Impact factor: 3.288

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.